Form 4: Guardant Health Chief Legal Officer Reports Stock Transactions

Guardant Health's Chief Legal Officer, John G. Saia, reported the acquisition of 1,020 shares and the disposal of 535 shares to cover tax obligations related to vesting restricted stock units.

Summary

• John G. Saia, Chief Legal Officer of Guardant Health, Inc., filed a Form 4 detailing changes in his beneficial ownership of company stock.
• On December 15, 2024, Mr. Saia acquired 1,020 shares of common stock through the vesting of restricted stock units.
• Also on December 15, 2024, 535 shares were disposed of to cover tax withholding obligations related to the vesting of the restricted stock units at a price of $34.76 per share.
• Following these transactions, Mr. Saia directly owns 33,560 shares of Guardant Health common stock and 6,117 restricted stock units.

Sentiment

Score: 7

Explanation: The document reflects routine transactions related to executive compensation, which is neither particularly positive nor negative. The sentiment is neutral to slightly positive due to the vesting of stock.

Positives

• The vesting of restricted stock units indicates that Mr. Saia is meeting the conditions of his compensation package.
• The acquisition of shares through vesting increases Mr. Saia's stake in the company.

Negatives

• The disposal of 535 shares, while for tax purposes, reduces Mr. Saia's overall holdings.

Risks

• There are no significant risks identified in this document.
• The transactions are routine and related to standard compensation practices.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate officers and directors who have transactions in their company's stock. It is a routine part of corporate governance and transparency.

Comparison to Industry Standards

• Form 4 filings are a standard practice for publicly traded companies in the United States, and this filing is consistent with those requirements.
• The transactions reported are typical for executives who receive stock-based compensation.

Stakeholder Impact

• The transactions have a minimal impact on stakeholders as they are routine and related to executive compensation.

Key Dates

Keywords

Guardant Health, Form 4, insider trading, stock transaction, restricted stock units, John G. Saia, beneficial ownership, tax withholding